Jacobson Pharma (2633) Schedules Board Meeting on 18 November 2025 to Review Interim Results

Bulletin Express

Nov 05, 2025

Jacobson Pharma Corporation Limited (2633) has announced that its board of directors will convene on 18 November 2025. The agenda includes considering and approving the interim results for the six months ended 30 September 2025, evaluating the payment of an interim dividend (if any), and handling other business matters.

According to the 5 November 2025 announcement, the board meeting will be chaired by Mr. Sum Kwong Yip, Derek, who also serves as Chairman and Chief Executive Officer. The board is composed of executive directors, a non-executive director, and several independent non-executive directors. The company secretary, Mr. YU Chun Kau, confirmed that the interim results are expected to be published following the board’s review.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1130222871"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1130222871\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1130222871?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-05 06:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1130222871","market":"hk","top_or_hot":-1,"title":"Jacobson Pharma (2633) Schedules Board Meeting on 18 November 2025 to Review Interim Results","media":"Bulletin Express","content":"<p>Jacobson Pharma Corporation Limited (2633) has announced that its board of directors will convene on 18 November 2025. The agenda includes considering and approving the interim results for the six months ended 30 September 2025, evaluating the payment of an interim dividend (if any), and handling other business matters.</p>\n<p>According to the 5 November 2025 announcement, the board meeting will be chaired by Mr. Sum Kwong Yip, Derek, who also serves as Chairman and Chief Executive Officer. The board is composed of executive directors, a non-executive director, and several independent non-executive directors. The company secretary, Mr. YU Chun Kau, confirmed that the interim results are expected to be published following the board’s review.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Jacobson Pharma (2633) Schedules Board Meeting on 18 November 2025 to Review Interim Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJacobson Pharma (2633) Schedules Board Meeting on 18 November 2025 to Review Interim Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-05 06:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Jacobson Pharma Corporation Limited (2633) has announced that its board of directors will convene on 18 November 2025. The agenda includes considering and approving the interim results for the six months ended 30 September 2025, evaluating the payment of an interim dividend (if any), and handling other business matters.</p>\n<p>According to the 5 November 2025 announcement, the board meeting will be chaired by Mr. Sum Kwong Yip, Derek, who also serves as Chairman and Chief Executive Officer. The board is composed of executive directors, a non-executive director, and several independent non-executive directors. The company secretary, Mr. YU Chun Kau, confirmed that the interim results are expected to be published following the board’s review.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02633","symbol_name":"雅各臣科研制药","start_time":0,"source_url":"","article_id":"1130222871","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1130222871","pubTimestamp":1762294916,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Jacobson Pharma Corporation Limited (2633) has announced that its board of directors will convene on 18 November 2025. The agenda includes considering and approving the interim results for the six...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02633":"雅各臣科研制药"},"translate_title":"雅各臣药业(2633)计划于2025年11月18日召开董事会审阅中期业绩","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02633":1},"content_text":"Jacobson Pharma Corporation Limited (2633) has announced that its board of directors will convene on 18 November 2025. The agenda includes considering and approving the interim results for the six months ended 30 September 2025, evaluating the payment of an interim dividend (if any), and handling other business matters.\nAccording to the 5 November 2025 announcement, the board meeting will be chaired by Mr. Sum Kwong Yip, Derek, who also serves as Chairman and Chief Executive Officer. The board is composed of executive directors, a non-executive director, and several independent non-executive directors. The company secretary, Mr. YU Chun Kau, confirmed that the interim results are expected to be published following the board’s review.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}